Simon began his patent career in private practice before joining the in-house department of a FTSE 100 multinational chemical company in 2012. As an in-house attorney, Simon was responsible for the patent portfolios of a contentious product area in the automotive catalysts sector. He has considerable experience in handling oppositions and appeals at the European Patent Office, and providing advice on patent validity and freedom-to-operate.
Simon returned to private practice in 2018 when he joined the London office of HGF. He draws on both his private practice and in-house experience to provide commercially-focused advice to his clients in relation to all patent matters.
1st class, Oxford University
DPhil, Organometallic Chemistry, Oxford University
Simon is a mentor for Oxford University’s Crankstart Careers Mentoring Programme.
The European Patent Office today confirmed in Decision G4/19 of the Enlarged board of Appeal that a European patent application can be refused for ‘double patenting’. Such a refusal can …Read article
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.